샘플 요청 목록

 카트 문의
시장보고서
상품코드
1941530

대장 스크리닝 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 지역별, 부문별 예측(2026-2033년)

Colon Screening Market Size, Share & Trends Analysis Report By Type (Test, Product), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), And Segment Forecasts, 2026 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

대장 스크리닝 시장 요약

세계의 대장 스크리닝 시장 규모는 2025년에 404억 1,000만 달러로 추정되며, 2033년까지 576억 5,000만 달러에 달할 것으로 예측됩니다.

2026년부터 2033년까지 CAGR 4.60%로 성장할 것으로 예상됩니다. 대장암 발병률 증가, 암 검진을 촉진하기 위한 정부의 노력 강화, 시장의 지속적인 기술 발전이 이 시장의 성장을 이끄는 주요 요인으로 꼽힙니다.

예를 들어, 2023년 12월, 메드트로닉은 내시경 검사 중 건강 문제를 자동으로 감지하는 플러그인 소프트웨어 개발사인 코스모제약과 인공지능(AI) 분야로 협업을 확대했습니다.

대장 질환의 증가 추세는 대장 검진 산업의 성장을 이끄는 주요 요인입니다. 심각한 소화기 질환인 대장암은 세계에서 세 번째로 많이 진단되는 암이며, 암 관련 사망 원인 중 두 번째로 많은 암입니다. 이러한 증가 추세는 조기 발견과 효과적인 검진 방법의 필요성을 강하게 시사하고 있습니다. 국제암연구소(IARC)에 따르면, 전 세계적으로 연간 약 190만 건의 신규 대장암이 보고되고 있으며, 가장 빈번하게 발생하는 악성 종양 중 하나입니다. 세계보건기구(WHO)는 유럽, 호주, 뉴질랜드 등의 지역에서 발병률이 가장 높다는 점을 강조하며, 그 주요 요인으로 생활습관, 식습관, 고령화 등을 꼽고 있습니다.

자주 묻는 질문

  • 대장 스크리닝 시장 규모는 어떻게 예측되나요?
  • 대장암 발병률 증가의 주요 원인은 무엇인가요?
  • 대장암은 세계에서 얼마나 많이 진단되나요?
  • 대장암 발병률이 높은 지역은 어디인가요?
  • 대장 스크리닝 시장의 주요 기업은 어디인가요?

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 대장 스크리닝 시장 변수, 동향 및 범위

제4장 대장 스크리닝 시장 세분화, 유형별, 2021-2033년

제5장 대장 스크리닝 시장 세분화, 지역별, 2021-2033년

제6장 경쟁 구도

KSM

Colon Screening Market Summary

The global colon screening market size was estimated at USD 40.41 billion in 2025 and projected to reach USD 57.65 billion by 2033, growing at a CAGR of 4.60% from 2026 to 2033. The growing prevalence of colorectal cancer, increasing government initiatives to encourage cancer screening, and ongoing technological advancements in the market are major factors driving the growth of this market.

For instance, in December 2023, Medtronic expanded its artificial intelligence collaboration with Cosmo Pharmaceuticals, the developer of plug-in software designed to detect health issues during endoscopic examinations automatically.

The increasing prevalence of colorectal diseases is a major driver of growth in the colon screening industry. Colorectal cancer, a severe gastrointestinal condition, ranks as the third most commonly diagnosed cancer and the second leading cause of cancer-related deaths worldwide. Its growing incidence highlights the critical need for early detection and effective screening methods. According to the International Agency for Research on Cancer (IARC), approximately 1.9 million new cases of colorectal cancer are reported annually across the globe, making it one of the most prevalent malignancies. The World Health Organization further emphasizes that regions such as Europe, Australia, and New Zealand exhibit the highest incidence rates, primarily due to lifestyle factors, diet, and aging populations.

Global Colon Screening Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides the analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global colon screening market report based on type, end use, and region:

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Test
    • Colonoscopy
    • Capsule Endoscopy
    • Imaging Tests
    • Virtual Colonoscopy
    • Magnetic resonance colonography (MRC)
    • Others
    • End Use, By Test
    • Hospitals
    • Outpatient Facilities
  • Product
    • Colonoscopes
    • Sigmoidoscopes
    • CT Scanners
    • Magnetic Resonance Imaging (MRI)
    • End Use, By Product
    • Hospitals
    • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Product outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Colon Screening Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Colon Screening: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis
  • 3.4. Case Study Analysis
  • 3.5. Recent Launches of Colon Screening Programs
  • 3.6. Technological Innovation in the Products used in Colon Screenings

Chapter 4. Colon Screening Market Segment Analysis, By Type, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2025 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global Colon Screening Market, by Type, 2021 to 2033
  • 4.5. Test
    • 4.5.1. Test Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Colonoscopy
      • 4.5.2.1. Colonoscopy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Capsule Endoscopy
      • 4.5.3.1. Capsule Endoscopy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Imaging Tests
      • 4.5.4.1. Imaging Tests Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.4.2. Virtual Colonoscopy
        • 4.5.4.2.1. Virtual Colonoscopy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.4.3. Magnetic resonance colonography (MRC)
        • 4.5.4.3.1. Magnetic resonance colonography (MRC) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. End Use, By Test
      • 4.5.6.1. Hospitals
        • 4.5.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.6.2. Outpatient Facilities
        • 4.5.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Product
    • 4.6.1. Product Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Colonoscopes
      • 4.6.2.1. Colonoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Sigmoidoscopes
      • 4.6.3.1. Sigmoidoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. CT Scanners
      • 4.6.4.1. CT Scanners Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Magnetic Resonance Imaging (MRI)
      • 4.6.5.1. Magnetic Resonance Imaging (MRI) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.6. End Use, By Product
      • 4.6.6.1. Hospitals
        • 4.6.6.1.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.6.2. Outpatient Facilities
        • 4.6.6.2.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Colon Screening Market Segment Analysis, By Region, 2021- 2033 (USD Million)

  • 5.1. Regional Market Share Analysis, 2025 & 2033
  • 5.2. Regional Market Dashboard
  • 5.3. Regional Market Snapshot
  • 5.4. Colon Screening Market Share by Region, 2025 & 2033:
  • 5.5. North America
    • 5.5.1. North America colon screening market, 2021 - 2033 (USD Million)
    • 5.5.2. U.S.
      • 5.5.2.1. U.S. colon screening market, 2021 - 2033 (USD Million)
    • 5.5.3. Canada
      • 5.5.3.1. Canada colon screening market, 2021 - 2033 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Mexico colon screening market, 2021 - 2033 (USD Million)
  • 5.6. Europe
    • 5.6.1. Europe colon screening market, 2021 - 2033 (USD Million)
    • 5.6.2. UK
      • 5.6.2.1. UK colon screening market, 2021 - 2033 (USD Million)
    • 5.6.3. Germany
      • 5.6.3.1. Germany colon screening market, 2021 - 2033 (USD Million)
    • 5.6.4. France
      • 5.6.4.1. France colon screening market, 2021 - 2033 (USD Million)
    • 5.6.5. Italy
      • 5.6.5.1. Italy colon screening market, 2021 - 2033 (USD Million)
    • 5.6.6. Spain
      • 5.6.6.1. Spain colon screening market, 2021 - 2033 (USD Million)
    • 5.6.7. Norway
      • 5.6.7.1. Norway colon screening market, 2021 - 2033 (USD Million)
    • 5.6.8. Sweden
      • 5.6.8.1. Sweden colon screening market, 2021 - 2033 (USD Million)
    • 5.6.9. Denmark
      • 5.6.9.1. Denmark colon screening market, 2021 - 2033 (USD Million)
  • 5.7. Asia Pacific
    • 5.7.1. Japan
      • 5.7.1.1. Japan colon screening market, 2021 - 2033 (USD Million)
    • 5.7.2. China
      • 5.7.2.1. China colon screening market, 2021 - 2033 (USD Million)
    • 5.7.3. India
      • 5.7.3.1. India colon screening market, 2021 - 2033 (USD Million)
    • 5.7.4. Australia
      • 5.7.4.1. Australia colon screening market, 2021 - 2033 (USD Million)
    • 5.7.5. South Korea
      • 5.7.5.1. South Korea colon screening market, 2021 - 2033 (USD Million)
    • 5.7.6. Thailand
      • 5.7.6.1. Thailand colon screening market, 2021 - 2033 (USD Million)
  • 5.8. Latin America
    • 5.8.1. Brazil
      • 5.8.1.1. Brazil colon screening market, 2021 - 2033 (USD Million)
    • 5.8.2. Argentina
      • 5.8.2.1. Argentina colon screening market, 2021 - 2033 (USD Million)
  • 5.9. MEA
    • 5.9.1. South Africa
      • 5.9.1.1. South Africa colon screening market, 2021 - 2033 (USD Million)
    • 5.9.2. Saudi Arabia
      • 5.9.2.1. Saudi Arabia colon screening market, 2021 - 2033 (USD Million)
    • 5.9.3. UAE
      • 5.9.3.1. UAE colon screening market, 2021 - 2033 (USD Million)
    • 5.9.4. Kuwait
      • 5.9.4.1. Kuwait colon screening market, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Profiles
    • 6.3.1. Olympus
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Platform benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. PENTAX Medical (Hoya Corporation)
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Platform benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. FUJIFILM Holdings Corporation
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Platform benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Medtronic
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Platform benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Ambu A/S
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Platform benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Baxter (Hillrom & Welch Allyn)
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Platform benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. EndoFresh (Daichuan medical)
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Platform benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Bracco
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Platform benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Varay Laborix
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Platform benchmarking
      • 6.3.9.4. Strategic initiatives
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제